Clinical Trials Sponsored by David Anderson

Total 4741 results

M.D. Anderson Cancer Center

Completed

Late Chronic Phase Chronic Myelogenous Leukemia

Leukemia

United States
M.D. Anderson Cancer Center

Completed

Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus

Mixed Tumor, Mullerian

United States
M.D. Anderson Cancer Center

Terminated

Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer

Breast Cancer

United States, Japan
M.D. Anderson Cancer Center

Withdrawn

Chemotherapy-Induced Peripheral Neuropathy Survey

Breast Cancer | Colorectal Cancer | Myeloma | Chemotherapy-induced Peripheral Neuropathy
M.D. Anderson Cancer Center

Completed

Pleural Catheters Versus Thoracoscopic Pleurodesis

Lung Cancer

United States
M.D. Anderson Cancer Center

Terminated

Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)

Lymphoma | Leukemia | Myeloma | Myeloproliferative Diseases

United States
M.D. Anderson Cancer Center

Completed

Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Leukemia | AML | MDS | CML

United States
M.D. Anderson Cancer Center

Withdrawn

SINF: Peripheral Neuropathy in Cancer Survivors

Peripheral Neuropathy
M.D. Anderson Cancer Center

Completed

Simple Versus Radical Hysterectomy for Stage I Cervical Cancer

Cervical Cancer

United States
M.D. Anderson Cancer Center

Completed

Patient and Family Decision Making in the Palliative Care Setting

Advanced Cancer

United States, Argentina, Chile, Guatemala
M.D. Anderson Cancer Center

Completed

Bone Response in Metastatic Breast Cancer Involving Bones

Breast Cancer | Bone Metastases

United States
M.D. Anderson Cancer Center

Completed

Chlorhexidine Gel Therapy for Cariogenic Oral Microflora

Head and Neck Cancer

United States
M.D. Anderson Cancer Center

Completed

Brain Tumor Patient-Caregiver Congruence, MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT)

Brain Tumor

United States
M.D. Anderson Cancer Center

Completed

Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies

Lymphoma

United States
M.D. Anderson Cancer Center

Completed

Sirolimus and Cetuximab in Advanced Malignancies

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

HAI Abraxane With Gemcitabine and Bevacizumab

Advanced Cancers

United States
M.D. Anderson Cancer Center

Terminated

An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin

Colorectal Carcinoma

United States
M.D. Anderson Cancer Center

Completed

HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver

Advanced Cancer | Liver Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

Health Habits and Cancer Risk Comparison Among Migrant Sri Lankans and Sri Lankans

Acculturation

United States, Sri Lanka
M.D. Anderson Cancer Center

Terminated

Pegasys in Patients With Chronic Myeloid Leukemia (CML)

Leukemia

United States
M.D. Anderson Cancer Center

Terminated

Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma

Retinoblastoma

United States
M.D. Anderson Cancer Center

Completed

Acupuncture for Treatment of Uncontrolled Pain: A Feasibility Study

Pain | Solid Tumors

United States
M.D. Anderson Cancer Center

Completed

Olanzapine in Patients With Advanced Cancer and Weight Loss

Weight Loss | Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Valproic Acid and Bevacizumab in Patients With Advanced Cancer

Advanced Cancer

United States
M.D. Anderson Cancer Center

Completed

Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer

Endometrial Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

18-F-Fluoroacetate as PET Imaging Agent

Breast Cancer | Prostate Cancer | Brain Cancer
M.D. Anderson Cancer Center

Completed

Erwinase Study in Patients With Acute Lymphoblastic Leukemia

Leukemia

United States
M.D. Anderson Cancer Center

Terminated

Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

Osteosarcoma

United States
M.D. Anderson Cancer Center

Completed

PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide

Esophageal Cancer | Lung Cancer | Gastrointestinal Disease

United States
M.D. Anderson Cancer Center

Completed

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

Dyspnea | Advanced Cancers

United States
M.D. Anderson Cancer Center

Withdrawn

Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation

Esophageal Cancer
M.D. Anderson Cancer Center

Terminated

Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)

Leukemia | Pediatric Cancer

United States
M.D. Anderson Cancer Center

Completed

Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging System

Head and Neck Cancer

United States
M.D. Anderson Cancer Center

Terminated

Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)

Leukemia

United States
M.D. Anderson Cancer Center

Withdrawn

PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation

Chronic Myelogenous Leukemia
Anderson Orthopaedic Research Institute

Completed

Knee Arthroplasty Performed With Conventional and Customized Instrumentation (CPI)

Knee Arthritis

United States
M.D. Anderson Cancer Center

Completed

A Study for Leukemia Patients With Life-Threatening Infections

Leukemia

United States
M.D. Anderson Cancer Center

Completed

Robotic-Assisted Laparoscopic Extended Pelvic Lymph Node Dissection for Transitional Cell Carcinoma of the Bladder

Bladder Cancer

United States
M.D. Anderson Cancer Center

Completed

Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer

Breast Cancer | Invasive Breast Carcinoma | Metastatic Breast Carcinoma

United States
M.D. Anderson Cancer Center

Withdrawn

Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload

Leukemia
M.D. Anderson Cancer Center

Terminated

Utility of Vancomycin Loading: A Pharmacokinetic Analysis in Critically Ill Patients

Infection

United States
M.D. Anderson Cancer Center

Completed

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
M.D. Anderson Cancer Center

Completed

Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

Peritoneal Cancer

United States
M.D. Anderson Cancer Center

Terminated

Melatonin Postoperative Sleep Study in Breast Cancer Patients

Breast Cancer

United States
M.D. Anderson Cancer Center

Completed

Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor

Solid Tumors

United States
M.D. Anderson Cancer Center

Completed

Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer

Head and Neck Cancer | Skin Cancer

United States
M.D. Anderson Cancer Center

Withdrawn

Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

Cutaneous T-cell Lymphoma
M.D. Anderson Cancer Center

Withdrawn

Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema

Head and Neck Cancer | Lymphedema | Oral Cancer | Oropharyngeal Cancer
M.D. Anderson Cancer Center

Completed

Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases

Lymphoma | Leukemia

United States

Clinical Trials Sponsored by David Anderson

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations